Phase Ib-II Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib, w/ Lenalidomide and Rituximab in Relapsed / Refractory Mantle Cell LymphomaAndré Goy, Ernest Richards, Lori A. Leslie et al.|Blood|2017Cited by 1